ReviewJournal of translational medicine2025

Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids.

Ann-Kathrin Lederer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.